Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy.
The Journal of clinical investigation
View this publicationThe Journal of clinical investigation
View this publicationProceedings of the National Academy of Sciences of the United States of America
View this publicationBritish journal of pharmacology
View this publicationImmunity
View this publicationPublication categories: Top publication
Immunity
View this publicationFrontiers in pharmacology
View this publicationInternational journal of cancer
View this publicationNeuroImage. Clinical
View this publicationJournal of molecular medicine (Berlin, Germany)
View this publicationFrontiers in immunology
View this publication